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Abstract
High-throughput sequencing of cDNA (RNA-seq) is used extensively to
characterize the transcriptome of cells. Many transcriptomic studies aim at
comparing either abundance levels or the transcriptome composition between
given conditions, and as a first step, the sequencing reads must be used as the
basis for abundance quantification of transcriptomic features of interest, such
as genes or transcripts. Various quantification approaches have been
proposed, ranging from simple counting of reads that overlap given genomic
regions to more complex estimation of underlying transcript abundances. In this
paper, we show that gene-level abundance estimates and statistical inference
offer advantages over transcript-level analyses, in terms of performance and
interpretability. We also illustrate that the presence of differential isoform usage
can lead to inflated false discovery rates in differential gene expression
analyses on simple count matrices but that this can be addressed by
incorporating offsets derived from transcript-level abundance estimates. We
also show that the problem is relatively minor in several real data sets. Finally,
we provide an R package ( ) to help users integrate transcript-leveltximport
abundance estimates from common quantification pipelines into count-based
statistical inference engines.
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Introduction
Quantification and comparison of isoform- or gene-level expression 
based on high throughput sequencing reads from cDNA (RNA-seq) 
are arguably among the most common tasks in modern computa-
tional molecular biology. Currently, one of the most widely used 
approaches amounts to defining the genomic locations of a set of 
non-overlapping targets (typically, genes) and using the number of 
aligned reads overlapping a target as a measure of its abundance, 
or expression level. Several software packages have been devel-
oped for performing such “simple” counting (e.g., featureCounts1 
and HTSeq-count2). More recently, the field has seen a surge in 
methods aimed at quantifying the abundances of individual tran-
scripts (e.g., Cufflinks3, RSEM4, BitSeq5, kallisto6 and Salmon7). These 
methods provide higher resolution than simple counting, and by 
circumventing the computationally costly read alignment step, some 
(notably, kallisto and Salmon) are also considerably faster. However, 
isoform quantification is more complex than the simple counting, 
due to the high degree of overlap among transcripts. Currently, 
there is no consensus regarding the optimal resolution or method for 
quantification and downstream analysis of transcriptomic output.
Another point of debate is the unit in which abundances are given. 
The traditional R/FPKM8,9 (reads/fragments per kilobase per 
million reads) have been largely superseded by the TPM10 (tran-
scripts per million), since the latter is more consistent across librar-
ies. Regardless, all these units attempt to “correct for” sequencing 
depth and feature length and thus do not reflect the influence of 
these on quantification uncertainty. In order to account for these 
aspects, most statistical tools for analysis of RNA-seq data operate 
instead on the count scale. Most of these tools were designed to be 
applied to simple read counts, and the degree to which their per-
formance is affected by using fractional estimated counts result-
ing from portioning reads aligning to multiple transcripts is still 
an open question. The fact that the most common sequencing pro-
tocols provide reads that are much shorter than the average tran-
script implies that the observed read counts depend on a transcript’s 
length as well as its abundance; thus, simple counts are arguably 
less accurate measures than TPMs of the true abundance of RNA 
molecules from given genes. The use of gene counts as input to sta-
tistical tools typically assumes that the length of the expressed part 
of a gene does not change across samples and thus its impact can be 
ignored for differential analysis.
In the analysis of transcriptomic data, as for any other application, 
it is of utmost importance that the question of interest is precisely 
defined before a computational approach is selected. Often, the 
interest lies in comparing the transcriptional output between dif-
ferent conditions, and most RNA-seq studies can be classified as 
either: 1) differential gene expression (DGE) studies, where the 
overall transcriptional output of each gene is compared between 
conditions; 2) differential transcript/exon usage (DTU/DEU) stud-
ies, where the composition of a gene’s isoform abundance spectrum 
is compared between conditions, or 3) differential transcript expres-
sion (DTE) studies, where the interest lies in whether individual 
transcripts show differential expression between conditions. DTE 
analysis results can be represented on the individual transcript level, 
or aggregated to the gene level, e.g., by evaluating whether at least 
one of the isoforms shows evidence of differential abundance.
In this report, we make and give evidence for three claims: 1) gene-
level estimation is considerably more accurate than transcript-level; 
2) regardless of the level at which abundance estimation is done, 
inferences at the gene level are appealing in terms of robustness, 
statistical performance and interpretation; 3) taking advantage of 
transcript-level abundance estimates when defining or analyzing 
gene-level abundances leads to improved DGE results compared to 
simple counting for genes exhibiting DTU. The magnitude of the 
effect in a given data set thus depends on the extent of DTU, and the 
global impact is relatively small in several real data sets analyzed 
in this study.
To facilitate a broad range of analysis choices, depending on the 
biological question of interest, we provide an R/Bioconductor 
package, tximport, to import transcript lengths and abundance 
estimates from several popular quantification packages and export 
(estimated) count matrices and, optionally, average transcript length 
correction terms (i.e., offsets) that can be used as inputs to common 
statistical engines, such as DESeq211, edgeR12 and limma13.
Data and methods
Throughout this manuscript, we utilize two simulated data sets and 
four experimental data sets (Bottomly14 [Data set 3], GSE6457015 
[Data set 4], GSE6924416 [Data set 5], GSE7216517 [Data set 6], 
see Supplementary File 1 for further details) for illustration. Details 
on the data generation and full records of the analyses are provided 
in the data sets and Supplementary File 1. The first simulated data 
set (sim1; Data set 1) is the synthetic human data set from Soneson 
et al.18, comprising 20,410 genes and 145,342 transcripts and is 
available from ArrayExpress (accession E-MTAB-3766). This data 
set consists of three biological replicates from each of two simulated 
conditions, and differential isoform usage was introduced for 1,000 
genes by swapping the relative expression levels of the two most 
dominant isoforms between conditions. For each gene in this data 
set, the total transcriptional output is the same in the two conditions 
(i.e., no overall DGE); it is worth noting that this is an extreme situ-
ation, but provides a useful test set for contrasting DGE, DTU and 
DTE. The second simulated data set (sim2; Data set 2) is a synthetic 
data set comprising the 3,858 genes and 15,677 transcripts from 
the human chromosome 1. It is available from ArrayExpress with 
accession E-MTAB-4119. Also here, we simulated two conditions 
with three biological replicates each. For this data set, we simulated 
both overall DGE, where all transcripts of the affected gene showed 
      Amendments from Version 1
In version 2 of the manuscript, we have reworded and improved 
the clarity of the text in several places, to better convey the 
differences between the contrasted approaches and clarify the 
questions that are addressed by each analysis. We have also 
expanded the Supplementary material with additional analyses 
of accuracy of abundance estimates among paralogous genes, 
and added more detailed descriptions of aspects such as the 
calculation of each abundance measure and the generation of 
the incomplete annotation files, information that was previously 
only available in the respective Datasets. The Discussion section 
has been extended, mainly to include a discussion of differential 
expression analysis methods incorporating variance estimates.
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the same fold change between the conditions (420 genes), differen-
tial transcript usage (DTU), where the total transcriptional output 
was kept constant but the relative contribution from the transcripts 
changed (420 genes) and differential transcript expression (DTE), 
where the expression of 10% of the transcripts of each affected gene 
was modified (422 genes, 528 transcripts). The three sets of modi-
fied genes were disjoint. Again, this synthetic data set represents an 
extreme situation compared to most real data sets, but provides a 
useful test case to identify underlying causes of differences between 
results from various analysis pipelines.
In addition to Data set 1–Data set 6, which contain all code for 
reproducing our analyses, further method descriptions are given in 
Supplementary File 1.
Data set 1.
http://dx.doi.org/10.5256/f1000research.7563.d114722 
Dataset 1 (html) contains all the R code that was used to perform the 
analyses and generate the figures for the sim1 data set30.
Data set 2.
http://dx.doi.org/10.5256/f1000research.7563.d114723 
Data set 2 (html) contains all the R code that was used to perform the 
analyses and generate the figures for the sim2 data set31.
Data set 3.
http://dx.doi.org/10.5256/f1000research.7563.d114724 
Data set 3 (html) contains all the R code that was used to perform the 
analyses and generate the figures for the Bottomly data set32.
Data set 4.
http://dx.doi.org/10.5256/f1000research.7563.d114725 
Data set 4 (html) contains all the R code that was used to perform the 
analyses and generate the figures for the GSE64570 data set33.
Data set 5.
http://dx.doi.org/10.5256/f1000research.7563.d114726 
Data set 5 (html) contains all the R code that was used to perform the 
analyses and generate the figures for the GSE69244 data set34.
Data set 6.
http://dx.doi.org/10.5256/f1000research.7563.d114730 
Data set 6 (html) contain all the R code that was used to perform the 
analyses and generate the figures for the GSE72165 data set35.
Gene abundance estimates are more accurate than 
transcript abundance estimates
To evaluate the accuracy of abundance estimation with transcript 
and gene resolution, we used the quasi-mapping mode of Salmon7 
(v0.5.1) to estimate the TPM for each transcript in each of the 
data sets. Gene-level TPM estimates, representing the overall tran-
scriptional output of each gene, were obtained by summing the cor-
responding transcript-level TPM estimates. For the two simulated 
data sets, the true underlying TPM of each feature was known and 
we could thus evaluate the accuracy of the estimates. Unsurpris-
ingly, gene-level estimates were more accurate than transcript-level 
estimates (Figure 1A, Supplementary Figures 4,5). We also derived 
TPM estimates from simple gene-level counts obtained from tradi-
tional alignment of the reads to the genome using STAR followed 
by counting with featureCounts, by dividing the read count for each 
gene with a reasonable measure of the length of the gene (the length 
of the union of its exons) and the total number of mapped reads, 
and scaling the estimates to sum to 1 million. The simple count 
estimates showed a lower correlation with the true TPMs than the 
Salmon estimates, in line with previous observations19. It is worth 
noting that we are comparing entire (typical) workflows, and that 
differences may also occur if the set of reads that STAR is able to 
align to the genome is not identical to the set of reads that are con-
tributing to the abundance estimation of Salmon. However, due to 
the large fraction of aligned reads and the high mapping rate with 
Salmon (both exceeding 99.8%, more than 95% of the reads were 
subsequently unambiguously assigned to genes by featureCounts), 
we do not expect this to have a major impact on the results shown 
in Figure 1A.
Gene-level estimates derived from both simple counts and Salmon 
tended to show a high degree of robustness against incompleteness 
of the annotation catalog, as evidenced from estimation errors after 
first removing (at random) 20% of the transcripts (Figure 1A, see 
also Supplementary File 1); in contrast, Salmon’s transcript esti-
mate accuracies deteriorated. To further compare the merits of 
genome alignment-based vs alignment-free quantification, espe-
cially in their handling of multi-mapping reads, we investigated 
the accuracy of the abundance estimates within sets of paralogous 
genes (Supplementary Figures 1–3). Also here, Salmon provided 
more consistently accurate estimates than STAR+featureCounts. 
From the bootstrap estimates generated by Salmon, we also esti-
mated the coefficient of variation of the abundance estimates. The 
gene-level estimates showed considerably lower variability than 
the transcript-level estimates in both simulated and experimen-
tal data (Figure 1B, Supplementary Figures 6,7). Taken together, 
these observations suggest that the gene-level estimates are more 
accurate than transcript-level estimates and therefore potentially 
allow a more accurate and stable statistical analysis. A further argu-
ment in favor of gene-level analysis is the unidentifiability of tran-
script expression that can result from uneven coverage caused by 
underlying technical biases. While some extent of coverage 
variability might be alleviated by corrections for sequence- or 
position-specific biases20, there remain cases where transcript 
expression cannot be inferred from data (Figure 1C). Intermediate 
approaches, grouping together “indistinguishable” features are also 
conceiveable21, but not yet standard practice.
DTE is more powerful and easier to interpret on gene 
level than for individual transcripts
DTE is concerned with inference of changes in abundance at tran-
script resolution, and thus invokes a statistical test for each tran-
script. We argue that this can lead to several complications: the first 
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is conceptual, since the rows (transcripts) in the result table will in 
many cases not be interpreted independently, since the researcher 
is often interested in comparing the results for transcripts from 
the same gene locus, and the second one is more technical, since 
the number of transcripts is considerably larger than the number 
of genes, which could lead to lower power due to the portioning 
of the total set of reads across a larger number of features and a 
potentially higher multiple testing penalty. We tested for DTE on 
the simulated data by applying edgeR12 to the transcript counts 
obtained from Salmon (the application of count models to estimated 
counts is discussed in the next Section), and represented the results 
as transcript-level p-values or aggregated these to the gene level by 
using the perGeneQValue function from the DEXSeq22 R package. 
Note that the transcript-level DTE test assesses the null hypothesis 
that individual transcripts do not change their expression, whereas 
the gene-level DTE test assesses the null hypothesis that all tran-
scripts from a given gene exhibit no change in expression. Fram-
ing the DTE question at the gene level results in higher power, 
without sacrificing false discovery rate control (Figure 2A). This 
is not surprising given the different null hypotheses, and, in fact, 
for many of the genes detected as true positives with the gene-level 
test, only a subset of the truly changing transcripts were detected 
(Supplementary Figure 8). We note that this type of gene-level 
aggregation may favor genes in which one transcript shows strong 
changes, and that other approaches to increase power against spe-
cific alternatives are conceivable, e.g., capitalizing on the rich 
collection of methods for gene set analysis.
While DTE analysis is more suitable than DGE analysis for detect-
ing genes with changes in absolute or relative isoform expression 
but no or only minor change in overall output (Supplementary 
Figure 9), we argue that even gene-level DTE results may suffer 
from lack of interpretability. DTE can manifest in several differ-
ent ways, as an overall differential expression of the gene or dif-
ferential relative usage of its transcripts, or a combination of the 
two (Figure 2B). We argue that the biological question of inter-
est is in many cases more readily interpretable as a combination 
of DGE and DTU, rather than DTE. It has been our experience 
that results reported at the transcript level are still often cast to 
the gene level (i.e., given a differentially expressed transcript, 
researchers want to know whether also other isoforms of the gene 
are changing), suggesting that asking two specific gene-level 
Figure 1 (sim2). A: Accuracy of gene- and transcript-level TPM estimates from Salmon and scaled FPKM estimates derived from simple 
counts from featureCounts, in one of the simulated samples (sampleA1). Spearman correlations are indicated in the respective panels. Top 
row: using the complete annotation. Bottom row: using an incomplete annotation, with 20% of the transcripts randomly removed. Gene-
level estimates are more accurate than transcript-level estimates. Gene-level estimates from Salmon are more accurate than those from 
featureCounts. B: Distribution of the coefficients of variation of gene- and transcript-level abundance estimates from Salmon, calculated across 
30 bootstrap samples of one of the simulated samples (sampleA1). Gene-level estimates are less variable than transcript-level estimates. 
C: An example of unidentifiable transcript-level estimates, as uneven coverage does not cover the critical regions that would determine the 
amount that each transcript is expressed, while gene-level estimation is still possible.
A B
C
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questions (Is the overall abundance changing? Are the isoform 
abundances changing proportionally?) trumps the interpretability 
of one broad question addressing the transcript abundances (Are 
there changes in any of the isoform expression levels?), despite 
the increased need for multiple testing correction associated with 
performing two tests for each gene rather than one. There are of 
course also situations when a transcript-centric approach provides 
superior interpretability, for example in targeted experiments 
where specific isoforms are expected to change due to an adminis-
tered treatment.
Incorporating transcript-level estimates leads to 
more accurate DGE results
DGE (i.e., testing for changes in the overall transcriptional out-
put of a gene) is typically performed by applying a count-based 
inference method from statistical packages such as edgeR12 or 
DESeq211 to gene counts obtained by read counting software 
such as featureCounts1, HTSeq-count2 or functions from the 
GenomicAlignments23 R package. A lot has been written about how 
simple counting approaches are prone to give erroneous results 
for genes with changes in relative isoform usage, due to the direct 
dependence of the observed read count on the transcript length24, 
and alternatives, such as Cuffdiff24, which utilizes estimated tran-
script abundances, have been proposed. However, the extent of the 
problem in real data has not been thoroughly investigated. Here, 
we show that taking advantage of transcript-resolution estimates 
(e.g., obtained by Salmon) in count-based inference methods can 
lead to improved DGE results. We propose two alternative ways of 
integrating transcript abundance estimates into the DGE pipeline: 
to define an “artificial” count matrix, or to calculate offsets that 
can be used in the statistical modeling of the observed gene counts 
from, e.g., featureCounts. Both approaches are implemented in the 
accompanying tximport R package (available from http://biocon-
ductor.org/packages/tximport).
For the DGE analyses, we defined three different gene-level 
count matrices for each data set (see also Supplementary File 1): 
1) using featureCounts from the Rsubread1 R package (denoted 
featureCounts below), 2) summing the estimated transcript counts 
from Salmon within genes (simplesum), 3) summing the esti-
mated transcript TPMs from Salmon within genes, and multiplying 
with the total library size in millions (scaledTPM). We note that 
the scaledTPM values are artificial values, transforming underly-
ing abundance measures to the “count scale” to incorporate the 
information provided by the sequencing depth. We further used 
the effective transcript lengths and estimated TPMs from Salmon 
to define average transcript lengths for each gene and each sample 
(normalization factors) as described in the Supplementary material, 
to be used as offsets for edgeR and DESeq2 when analyzing the 
featureCounts and simplesum count matrices (featureCounts_
avetxl and simplesum_avetxl).
Overall, the counts obtained by all methods were highly correlated 
(Supplementary Figures 10–12), which is not surprising since any 
differences are likely to affect a relatively small subset of the genes. 
In general, the simplesum and featureCounts matrices led to similar 
conclusions in all considered data sets, even though there are differ-
ences between the two approaches in terms of how multi-mapping 
reads and reads partly overlapping intronic regions are handled25. 
Previous studies have also shown that some loss of sensitivity for 
certain genes may be encountered from discarding multi-mapping 
fragments, which may be recovered through the use of transcript 
abundance estimators such as Salmon21. The concordance between 
simplesum and featureCounts results also suggests that statistical 
methods based on the Negative Binomial assumption are applicable 
also to summarized, gene-level estimated counts, which is further 
supported by the similarity between the p-value histograms as well 
as the mean-variance relationships observed with the three types of 
count matrices (Supplementary Figures 13–18).
Figure 2 (sim2). A: DTE detection performance on transcript- and gene-level, using edgeR applied to transcript-level estimated counts from 
Salmon. The statistical analysis was performed on transcript level and aggregated for each gene using the perGeneQValue function from the 
DEXSeq R package; aggregated results show higher detection power. The curves trace out the observed FDR and TPR for each significance 
cutoff value. The three circles mark the performance at adjusted p-value cutoffs of 0.01, 0.05 and 0.1. B: Schematic illustration of different 
ways in which differential transcript expression (DTE) can arise, in terms of absence or presence of differential gene expression (DGE) and 
differential transcript usage (DTU).
A B
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Accounting for the potentially varying average transcript length 
across samples when performing DGE, either in the definition of the 
count matrix (scaledTPM) or by defining offsets (featureCounts_ 
avetxl, simplesum_avetxl), led to considerably improved false 
discovery rate (FDR) control compared to using the observed 
featureCounts or aggregated Salmon counts directly (Figure 3A, 
Table 1). It is important to note that this improvement is entirely 
attributable to an improved handling of genes with changes in isoform 
composition between the conditions (Figure 3B, Supplementary 
Figure 19), that we purposely introduced strong signals in the simu-
lated data set in order to pinpoint these underlying causes, and that 
the overall effect in a real data set will depend on the extent to 
which considerable DTU is present. Experiments on various real 
data sets (Supplementary Figure 20) show only small differences 
in the collections of significant genes found with the simplesum 
and simplesum_avetxl approaches, suggesting that the extent of 
Figure 3 (sim2). A: DGE detection performance of edgeR applied to three different count matrices (simplesum, scaledTPM, featureCounts), 
with or without including an offset representing the average transcript length (for simplesum and featureCounts, avetxl indicates that such 
offsets were used). Including the offset or using the scaledTPM count matrix leads to improved FDR control compared to using simplesum or 
featureCounts matrices without offset. The curves trace out the observed FDR and TPR for each significance cutoff value. The three circles 
mark the performance at adjusted p-value cutoffs of 0.01, 0.05 and 0.1. B: stratification of the results in A by the presence of differential 
isoform usage. The improvement in FDR control seen in A results from an improved treatment of genes with differential isoform usage, while 
all methods perform similarly for genes without differential isoform usage.
Table 1 (sim1). Observed false positive rates from a differential gene expression analysis using edgeR applied to 
various count matrices (with a nominal p-value cutoff at 0.05), limited to genes with true underlying differential 
isoform usage (recall that no genes are truly differentially expressed in this data set). The results are stratified by 
“effect size” (the difference in relative abundance between the two differentially used isoforms) and the length ratio 
between the longer and the shorter of the differentially used isoforms. FPRs below the nominal p-value threshold (0.05) 
are marked in bold. For more details, see Data set 1.
simplesum featureCounts simplesum_avetxl featureCounts_avetxl scaledTPM
[0,0.33), [1,1.34) 0.019 0.019 0.023 0.023 0.023
[0.33,0.67), [1,1.34) 0.059 0.059 0.059 0.059 0.059
[0.67,1), [1,1.34) 0.000 0.053 0.053 0.053 0.053
[0,0.33), [1.34,2.57) 0.075 0.070 0.070 0.065 0.065
[0.33,0.67), [1.34,2.57) 0.240 0.220 0.050 0.033 0.066
[0.67,1), [1.34,2.57) 0.420 0.540 0.038 0.077 0.038
[0,0.33), [2.57,35.4] 0.150 0.140 0.037 0.043 0.037
[0.33,0.67), [2.57,35.4] 0.650 0.650 0.060 0.060 0.034
[0.67,1), [2.57,35.4] 0.970 0.970 0.034 0.034 0.034
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the problem in many real data sets is limited, and that most find-
ings obtained with simple counting are not induced by counting 
artifacts. Further support for this conclusion is shown in Figure 4 
(see also Supplementary Figures 21–23 and Supplementary 
Table 1), where log-fold change estimates from edgeR, based on 
the simplesum and scaledTPM matrices, are contrasted. For the 
genes with induced DTU in the sim2 data set, log-fold changes 
based on the simplesum matrix are overestimated, as expected. 
However, this effect is almost absent in all the real data sets, 
again highlighting the extreme nature of our simulated data and 
suggesting that the effect of using different count matrices is 
considerably smaller for many real data sets. Table 1 further sug-
gests that the lack of error control for simplesum and featureCounts 
matrices is more pronounced when there is a large difference in 
length between the differentially used isoforms. In the group with 
smallest length difference, where the longer differentially used 
isoform is less than 34% longer than the shorter one, all approaches 
controlled the type I error satisfactorily. It is worth noting that 
among all human transcript pairs in which both transcripts belong 
to the same gene, the median length ratio is 1.85, and for one third 
of such pairs the longer isoform is less than 38% longer than the 
shorter one (see Data set 1).
Figure 4. Comparison of log-fold change estimates from edgeR, based on simplesum and scaledTPM count matrices, in four different 
data sets. For the simulated data set (sim2), where signals have been exaggerated to pinpoint underlying causes of various observations, 
genes with induced DTU (whose true overall log-fold change is 0) show a clear overestimation of log-fold changes when using simplesum 
counts. However, none of the real data sets contain a similar population of genes, suggesting that for many real data sets, simple gene 
counting leads to overall similar conclusions as accounting for underlying changes in transcript usage.
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Discussion
In this article, we have contrasted transcript- and gene-resolution 
analyses in terms of both abundance estimation and statistical 
inference, and illustrated that gene-level results are often more 
accurate, powerful and interpretable than transcript-level results. 
Not surprisingly, however, accurate transcript-level estimation 
and inference play an important role in deriving appropriate gene-
level results, and it is therefore imperative to continue improving 
abundance estimation and inference methods applicable to indi-
vidual transcripts, since misestimation can propagate to the gene 
level. We have shown that when testing for changes in overall gene 
expression (DGE), traditional gene counting approaches may lead 
to an inflated false discovery rate compared to methods aggregat-
ing transcript-level TPM values or incorporating correction factors 
derived from these, for genes where the relative isoform usage dif-
fers between the compared conditions. These correction factors can 
be calculated from the output of transcript abundance programs, 
using e.g., the provided R package (tximport). It is important to 
note that the average transcript length offsets must account for the 
differences in transcript usage between the samples and thus using 
(sample-independent) exon-union gene lengths will not improve 
performance.
On the six data sets studied here, simple counting with feature-
Counts led to very similar conclusions as estimated gene counts 
from Salmon, when combined with count-based statistical infer-
ence tools such as edgeR and DESeq2. Moreover, p-value distri-
butions and mean-variance relationships were similar for actual 
and estimated counts. Taken together, this suggests that the nega-
tive binomial assumption made by the count-based tools is flexible 
enough to accommodate also estimated counts. All evaluated count-
ing approaches, with and without the inclusion of average transcript 
length offsets, gave comparable DGE results for genes where DTU 
was not present. Thus, the extent of the FDR inflation in experi-
mental data depends on the extent of DTU between the compared 
conditions; notably, our simulation introduced rather extreme levels 
of DTU, hence the inflated FDR, and the difference between the 
approaches was considerably smaller in real data sets. Recent stud-
ies have also shown that many genes express mainly one, dominant 
isoform26 and for such genes, we expect that simple gene counting 
will work well.
All evaluations in this study were performed using well-established 
count-based differential analysis tools. These methods take as input 
a matrix of counts, which is assumed to correctly represent the 
origin of each read in a particular set of libraries. However, due 
to sequence similarities among transcripts or genes, there is often 
a hidden uncertainty in the feature abundance estimates, even 
when the set of input reads is fixed. With the development of fast, 
alignment-free abundance estimation methods, this uncertainty 
can now be estimated rapidly using bootstrap approaches (see e.g. 
Figure 1b). Method development is currently underway in the 
field to account for this uncertainty in the differential expression 
analysis (e.g., MetaDiff27, sleuth6), which has the potential to 
improve performance of both DTE and DGE analyses. If such 
methods are based on (potentially transformed) aggregated tran-
script counts as gene-level abundance measures, DGE analysis will 
still be affected by the presence of DTU, and thus could benefit 
from the inclusion of average transcript length offsets, or by instead 
using the sum of transcript TPMs as gene abundance measures.
Our results highlight the importance of carefully specifying the 
question of interest before selecting a statistical approach. Summa-
rization of abundance estimates at the gene level before performing 
the statistical testing should be the method of choice if the interest 
is in finding changes in the overall transcriptional output of a gene. 
However, it is suboptimal if the goal is to identify genes for which 
at least one of the transcripts show differences in transcriptional 
output, since it may miss genes where two transcripts change in 
opposite directions, or where a lowly expressed transcript changes. 
For gene-level detection of DTE (that is, whether any transcript 
showed a change in expression between the conditions), statisti-
cal testing applied to aggregated gene counts led to reduced power 
and slightly inflated FDR compared to performing the statistical 
test on the transcript level and aggregating results within genes 
(Supplementary Figure 9). Statistical inference on aggregated tran-
script TPMs (scaledTPM) showed low power for detecting changes 
that did not affect the overall transcriptional output of the gene, as 
expected. An alternative to DTE analysis, for potential improved 
interpretability, is to perform a combination of DGE and DTU 
analyses, both resulting in gene-level inferences. Table 2 summa-
rizes our results and give suggested workflows for the different 
types of analyses we have considered.
Table 2. Summary of suitable analysis approaches for the three types of comparative analyses discussed in 
the manuscript (DGE, DTE and DTU).
Task Input data Software (examples) Post-processing
DGE Aggregated transcript counts + 
average transcript length offsets, or 
simple counts + average transcript 
length offsets
Salmon, kallisto, BitSeq, RSEM
tximport
DESeq2, edgeR, voom/limma
DTE Transcript counts Salmon, kallisto, BitSeq, RSEM Optional gene-level 
aggregation
tximport
DESeq2, edgeR, sleuth, voom/limma
DTU/DEU Transcript counts or bin counts, 
depending on interpretation potential18
Salmon, kallisto, BitSeq, RSEM Optional gene-level 
aggregation
DEXSeq
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Finally, we note that abundance estimation at the gene level can 
reduce the impact of technical biases on expression levels, which 
have been shown to lead to estimation errors, such as expression 
being attributed to the wrong isoform28. Non-uniform coverage 
from amplification bias or from position bias (3’ coverage bias 
from poly-(A) selection) can result in unidentifiable transcript-level 
estimation. While correction of technical artifacts in coverage can 
be attempted computationally, through estimation of sequence- and 
position-specific biases20, we note that such errors and estima-
tion problems are also minimized when summarizing expression 
to the gene level. This being said, there may of course be situa-
tions where a direct transcript-level analysis is appropriate. For 
example, in a cancer setting where a specific deleterious splice 
variant is of interest (e.g., AR-V7 in prostate cancer29), inferences 
directly at the transcript level may be preferred. However, while this 
may be preferred for individual known transcripts, transcriptome-
wide differential expression analyses may not be warranted, given 
the associated multiple testing cost.
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In this manuscript, the authors address a few questions of considerable (and perennial) interest in the
analysis of RNA-seq data. Specifically, they provide evidence that, using available methods (e.g. DESeq2
/ edgeR), assessing differential expression at the gene-level (DGE) is more robust than at the transcript
level (DTE). Further, they convincingly argue that estimating abundance at the level of transcripts, and
then aggregating these abundances to the gene level leads to improved estimation of differential gene
expression. They demonstrate that one of the major factors in this improved estimation is the availability
of a sample-specific feature length for each gene (derived from the abundance-weighted length of the
expressed transcripts of this gene), which is not possible to obtain with any fixed gene model used by
count-based methods. Finally, the authors argue that much of the analysis of interest at the transcript
level does not actually require differential transcript expression testing, but rather can be inferred from a
combination of DGE and differential transcript usage (DTU); this is an interesting proposition that merits
further discussion and analysis. Overall, this is a well-written paper, with extensive and compelling
supplementary and supporting data, that addresses a ubiquitous analysis task involving RNA-seq.  It
should be of broad interest to the community and makes a valuable contribution. The accompanying
software, , is user-friendly and makes it easy to apply the type of analysis recommended herein; ittximport
too should be widely useful.
Major comments:
It would be very useful to provide the equations used for calculating each of the abundance measured
considered directly. Section 4 of the supplementary information is useful to this end, but the reader still
has to search a bit to see exactly how each metric is computed (though the fantastic R-Markdown
included with the figures means that these computations can be found explicitly).
Similarly, it would be useful to the reader to provide a description, in prose, of how specific experiments
were performed (again, the reproducible nature of most of these experiments makes tracking down this
information possible, but sometimes time-consuming). For example, how, precisely, was removal of
transcripts handled at the level of the genome annotation? If a transcript consists only of constitutive
exons, were all of those exons retained in the genome annotation used for STAR + featureCounts, while
the transcript was removed in the Salmon index?  
The result that transcript-level abundance estimation is more sensitive to the removal of transcripts than
gene-level abundance estimation — this seems intuitive. However, I agree with Dr. Floor’s suggestion
that:
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that:
"The assertion that “simple counts tended to show a high degree of robustness against incompleteness of
the annotation catalog, as evidenced from estimation errors after first removing (at random) 20% of the
transcripts” seems misleading since Salmon-derived gene-level abundances actually show a higher
Spearman correlation than count-derived gene-level abundances when subjected to removing a random
20% of transcripts.”
I would suggest rewording this sentence, as the main result seems to be that gene-level analysis is more
robust to an incomplete annotation than transcript-level analysis. Transcript-level abundance estimation
followed by gene-level analysis seems to perform just as well (actually, better) than gene-level counting in
this scenario.
The experiments in the section “Incorporating transcript-level estimates leads to more accurate DGE
results” suggests the (reasonable) interpretation that the main benefit of incorporating transcript-level
abundance estimates when assessing DGE is a more accurate measure of the “feature” length of the
gene. The authors state “ It is important to note that this improvement is entirely attributable to an
improved handling of genes with changes in isoform composition between the conditions.” This is
supported by the fact that using the abundance-weighted average transcript length (i.e. offsets) with
counting based approaches improves the results substantially.  However, one other place where
transcript-level abundance estimates are useful in the context of DGE is when assessing the expression
of paralogous genes. While most multi-mapping reads that derive from different isoforms of the same
gene will be uniquely mappable at the level of the genome, and hence will be included in the counts for
that gene, reads that map ambiguously among paralogs may not be. In such cases, count-based methods
do not have a principled way of apportioning a read between the paralogs involved, and discarding
multi-mapping reads may negatively affect estimation of the abundance of the paralogs, even at the gene
level. While this case is likely much less common than mis-estimation of DGE as a result of DTU, it is
certainly of biological interest. I would suggest adding an analysis, restricted to sets of paralogous genes,
comparing how the different approaches perform in this case. This may help to highlight the importance of
not only deriving appropriately weighted and sample-dependent lengths for genes, but also on resolving
multi-mapping ambiguity that occurs between genomically distinct loci.
The argument that most transcript-level analyses of interest may be addressed by looking at DGE in
conjunction with DTU is an interesting one. It is certainly that case that not all tasks for which DTE is used
actually require assessing differential expression at the transcript level. One issue with the DGE +
DTU-based analysis which warrants further discussion in the manuscript is that I believe that this
approach, too, would require correcting for multiple hypothesis testing. Specifically, one is testing both the
DGE and the DTU hypotheses for each gene (or for a relevant subset of interest). The correction here is
likely to be less harsh than in the case of assessing DTE, but is still worth discussing.
Minor comments:
As per Dr. Floor’s statement, Salmon (and Sailfish) also incorporate sequence-specific bias correction.
Further, RSEM and Salmon (and a few other transcript-level abundance estimation tools) also incorporate
the modeling of non-uniform fragment start position distributions. Of course, modeling a non-uniform start
position distribution cannot overcome a complete lack of sampling in critical regions that might make
determining transcript-level fragment assignment impossible, but it may help in properly apportioning an
ambiguously-mapped fragment between transcripts depending on its relative position in each.
One potential added source of variability here is that all Salmon estimates presented in the manuscript
make use of Salmon’s quasi-mapping of reads, while the STAR + featureCount pipeline makes use of
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make use of Salmon’s quasi-mapping of reads, while the STAR + featureCount pipeline makes use of
“traditional” alignments. This is the primary intended usage mode of Salmon, and absolutely does
represent a “typical” pipeline for methods that avoid alignment (Salmon, Sailfish, kallisto). However, it
would probably be best to mention this as a potential (though likely negligible) additional source of
variability.
In the discussion, the authors argue that “... it is therefore imperative to continue improving abundance
estimation and inference methods applicable to individual transcripts, since misestimation can propagate
to the gene level.” This is, of course, an important and valid suggestion. Another direction, on which it
would be useful to get the authors’ thoughts and suggestions, is the development of differential
expression tools (at either the transcript or gene level) that can make use of the variance estimates that
some tools (like Salmon) can provide. To what extent might incorporating this information help control
false positive rates and improve DTE or even DGE estimates?
I have read this submission. I believe that I have an appropriate level of expertise to confirm that
it is of an acceptable scientific standard.
 No competing interests were disclosed.Competing Interests:
Author Response 19 Feb 2016
, University of Zurich, SwitzerlandMark Robinson
Thank you for taking the time to read and review our paper. As per your suggestions, we have
expanded the supplementary pdf document with equations defining each of the abundance
measures that we used as well as a detailed description of the generation of the incomplete
annotation files. We have also reworded the paragraph discussing the influence of an incomplete
annotation catalog, and added further discussion points regarding multiple testing correction for
DGE+DTU as well as regarding new methods incorporating variance estimates into the differential
analysis. However, a deeper discussion of the latter point falls outside the scope of this article.
 
We found your suggestion to restrict the abundance accuracy comparison to paralogous genes
interesting, and the supplement has been expanded with several examples comparing the
accuracy of gene-level abundance estimates from Salmon and from STAR+featureCounts,
restricted to sets of paralogous genes. While we see a clear advantage of Salmon for many of the
paralogous gene groups, the overall difference is only slightly larger for sets of paralogous genes
compared to random sets of genes (as can be seen in the revised version of Dataset 1). In
addition, we have added the following text to the relevant section in the results:
 
“...suggesting that the extent of the problem in many real data sets is limited... though some loss of
sensitivity for certain genes may be encountered from discarding multi-mapping fragments, which
may be recovered through the use of transcript abundance estimators such as Salmon.”
 
While we acknowledge that many of the popular transcript abundance estimation methods
incorporate some type of bias estimation/correction (albeit not at the fragment level), and that it is
definitely an important (and difficult) research area, a thorough discussion on the relative merits of
different bias correction approaches is outside the scope of this paper. We have added citations to
relevant literature on coverage bias, have simplified and clarified the last paragraph of the
discussion, and have reworded the sentence about unidentifiable estimation due to coverage
biases:
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“While some extent of coverage variability might be alleviated by corrections for sequence- or
position-specific biases, there remain cases where transcript expression cannot be inferred from
data ( Figure 1C)” 
 No competing interests were disclosed.Competing Interests:
 04 January 2016Referee Report
doi:10.5256/f1000research.8143.r11761
 Stephen N. Floor
Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA, USA
Soneson, Love and Robinson tackle a crucial question for analysis of RNA deep sequencing data in this
manuscript: what is the role of transcript diversity in the accuracy and statistical power associated with
measurements of gene expression? The authors make and convincingly show three claims: gene-level
estimation and inferences are more robust than those at the transcript-level, and incorporating
transcript-level quantification into gene-level abundance leads to improved differential expression testing. 
The claims are convincingly proven, the manuscript is well written, and the subject matter is of
considerable interest. Furthermore, the described R package should be of broad interest to thetximport 
RNA deep sequencing community.
 
Overall comments:
 
It may be useful to indicate explicitly in the text that the methods are contained within the (excellently
written and formatted) supplementary material, as this was not apparent. It might be clearest to create a
specific methods section that just references supplementary file 1.
 
The clarity of scatter plots with more than ~hundreds of points (e.g. Figure 1A) could be improved by
using partially transparent points to visualize density.
 
Introduction:
 
Paragraph 1: Cufflinks, RSEM and Bitseq are grouped with kallisto and Salmon and it is then stated that
some of these methods bypass read alignment. It would be clearer if this were reworded to avoid the
ambiguity as to which methods avoid read alignment.
 
Paragraph 4: The third claim could be presented more clearly. While it is interesting that simple counting
performs similarly to transcript-level quantification procedures, it seems more interesting to this reviewer
that incorporating transcript-level information improves the accuracy of differential expression testing at
the gene level. Perhaps these two concepts can be combined into one more concise point?
 
Results:
 
The assertion that “simple counts tended to show a high degree of robustness against incompleteness of
the annotation catalog, as evidenced from estimation errors after first removing (at random) 20% of the
transcripts” seems misleading since Salmon-derived gene-level abundances actually show a higher
Spearman correlation than count-derived gene-level abundances when subjected to removing a random
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Spearman correlation than count-derived gene-level abundances when subjected to removing a random
20% of transcripts. Figure 1a bottom left shows that transcript-level abundances are strongly affected by
removal of 20% of transcripts, but that gene-level abundances are not strongly changed whether
estimated using counts or Salmon. This statement should be reworded.
 
Two concerns are raised about DTE. It is certainly true that reads are spread across more features when
performing DTE as opposed to DGE.However, it is not apparent why analysis of DTE involves grouping of
transcripts together for interpretation. DTE implies analysis at the transcript level and therefore no
grouping, while DGE could involve some level of grouping of transcripts or quantification at the gene level
from the start. The clarity of this could be improved.
 
It is a very interesting idea to separately frame questions regarding DGE and DTU, which should be
adopted widely, as the two are separable questions.
 
The authors state one possible workflow towards DGE analysis in the section “Incorporating
transcript-level estimates leads to more accurate DGE results.” Alternative pipelines (e.g. cuffdiff) could
be presented in brief.
 
The observation that simplesum and featureCounts results are highly correlated and therefore that
statistical methods based on the Negative Binomial distribution can be used on estimated counts seems
of greater importance than is emphasized in the text. This should be elaborated upon in the discussion,
since this means that estimated counts from kallisto, express, salmon, etc can be used directly by
statistical packages assuming a NB distribution (edgeR, DESeq2, etc). This point is frequently debated in
discussions of how to rigorously analyze sequencing data. The conclusion here that NB applies to
estimated counts is thus quite important.
 
Please explain the meaning of the name for each curve in the legend for Figure 3 (i.e. specify that “avetxl”
means using the offset corresponding to average transcript length.
 
Discussion:
 
The assertion that “gene-level results are more accurate, powerful and interpretable than transcript-level
results” seems an oversimplification given the result that incorporating transcript-level quantification leads
to improved DGE detection performance (e.g. Fig 3).
 
Please cite at minimum Roberts , (2011) regarding sequence bias correction as this has beenet al.
implemented in cufflinks, express and kallisto. Other relevant papers should also be included here, as
attempts have been made to address both positional and sequence-specific bias in RNA sequencing
data.
 
Supplement:
 
The usability of the supplemental info could be improved by substituting rasterized for vectorized plots for
those with ~hundreds of points.
 
Please explain the meaning of the name for each curve in the legend for Supplemental Figure 5.
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I have read this submission. I believe that I have an appropriate level of expertise to confirm that
it is of an acceptable scientific standard.
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Author Response 19 Feb 2016
, University of Zurich, SwitzerlandMark Robinson
Thank you for taking the time to read and review our paper. In the revised version, we have
improved the clarity and usability of the figures and the supplement by using partially transparent
points and extending the figure captions. We have also modified the main text to refer more clearly
to the method information provided in the supplementary material, and improved the clarity of the
text in several places, according to your suggestions.
 
For additional comments regarding references to bias correction studies, please see responses to
Rob Patro. 
 No competing interests were disclosed.Competing Interests:
Discuss this Article
Version 1
Author Response 02 Feb 2016
, University of Zurich, SwitzerlandCharlotte Soneson
Hi Nick,
thanks for your comments. 
Regarding the increased accuracy and robustness of gene-level estimates compared to transcript-level
ones (even with the full annotation, bootstrap variances of gene estimates are lower than those of
transcript estimates), we agree that it is not surprising. However, we still found it worth pointing out since it
implies that in some situations, gene-level statistical analyses may be preferred due to the increased
precision of the input data.
For your second point, note that Figure 2 does not in fact compare DGE to DTE, but rather DTE
summarized on gene- and transcript-level. You are of course right that just reducing the number of tests
does not automatically result in higher power. Instead, the difference between the gene- and
transcript-level results in Figure 2 is largely due to the different null hypotheses (as outlined in the text)
and, consequently, the type of signal we require to call a feature (gene or transcript) significant. In fact, the
gene-level summarized analysis is answering a somewhat "easier" question, from the sensitivity point of
view. Consider for example a gene with 5 differentially expressed transcripts. On the gene level, we can
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view. Consider for example a gene with 5 differentially expressed transcripts. On the gene level, we can
reach a power of 100% for this gene if of the transcripts is considered significantly DE. On theany 
transcript level, we would need  of the transcripts to be significant to reach the same power. Looking atall
this particular data set, for many of the genes that are found as true positives with the gene level test, not
all truly DE transcripts are actually detected. This explains the lower power of the transcript-level analysis.
We will clarify this in the revised version. Regarding the choice of DTE vs DGE+DTU, it is clear that one
solution will not always be the optimal choice, and it will likely depend on the particular problem as well as
on the person interpreting the results. However, we have found that in many of our own collaborations, the
biological question can be more clearly stated in terms of DGE+DTU (not necessarily performed
sequentially, rather in parallel). Part of the reason for this discussion was to encourage researchers to think
about what question they really want to answer before starting their analyses. 
Finally, note that the only place where we are actually comparing "summarizing DTE at the gene level" and
DGE is in Supplementary Figure 5 (on simulated data). In Figures 3-4, the question of interest is always
comparing the total transcriptional output of a gene between conditions (i.e., DGE), and all methods are
based on aggregating gene abundance estimates before the statistical test is applied. As you note, we
don't see a big global effect of including offsets accounting for average transcript lengths for real data.
However, there may of course still be important effects for individual genes, where isoforms of different
lengths are expressed in different conditions. 
Thanks again for your comments, and we are glad you found the paper useful!
 No competing interests were disclosed.Competing Interests:
Reader Comment (  ) 29 Jan 2016Member of the F1000 Faculty
, The Barton Group, Division of Computational Biology College of Life Sciences, UniversityNick Schurch
of Dundee, UK
I read this work with great interest for a literature review and found it engaging and informative. I thought I'd
post my resulting thoughts here.
This paper focusses on the advantages and disadvantages of performing differential expression analysis
at either the gene level or the transcript level, relying heavily on simulated data. Initially the authors use
simulated data to show that gene level estimations of expression are more stable then transcript level
estimations. They do this by showing that with the removal of ~20% of the transcripts from the annotation,
the quantification the transcript level estimations becomes less accurate while the gene level estimation
remains relatively unchanged. I found this conclusion to be unsurprising; the transcripts are the primary
annotation used for transcript level quantification but are not the primary annotation for the gene level
estimation. Except in rare cases where the removal of the transcripts result in the removal of the parent
gene or removal of the longest transcripts results in a considerable change in the length of the parent
gene, the gene annotation will remain largely unaltered by the removal of transcripts.
The authors then consider the performance of differential expression at the gene level (DGE) vs differential
expression at the transcript level (DTE), concluding that inference at the gene level is more robust, easier
to interpret and has better statistical performance. While the argument for improved robustness is
compelling, I found the arguments for improved inference and statistical performance a little misleading.
The improved statistical performance of DGE is due essentially to performing fewer tests. By this
argument, anything that reduced the number of tests always improves the inference (e.g., using a smaller
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argument, anything that reduced the number of tests always improves the inference (e.g., using a smaller
annotation) which is clearly not always the case. The authors also suggest that rather than identifying DTE,
a better approach with information summarized at the gene level may be to first identify which genes are
changing and then identify differential isoform usage. There is no clear demonstration of the advantages of
this approach or what the appropriate multiple testing correction is for the combined analysis. In particular,
l find the interpretability of DTE far more straightforward than the combined approach.
The paper also examined the differences between the differential gene expression conclusions resulting
from summarizing DTE at the gene level and DGE called on simple gene counts on both simulated and
real data and find that, again somewhat unsurprisingly in my opinion, that the difference in the results is
smaller and less obvious for real datasets than for the simulated data where they have added a strong
signal. I found the evidence for using an adjusted transcript length is compelling despite the relatively small
apparent impact it has for real datasets.
All in all I liked the paper and it was interesting to talk about it and discuss the issues it raises with my
group.
 No competing interests were disclosed.Competing Interests:
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